Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A First in Human Phase I Study of INVAC-1 as a Single Agent in Patients With Advanced Cancer

NCT02301754 is registered in ClinicalTrials.gov with Invectys as lead sponsor.

NCT NCT02301754
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02301754 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A First in Human Phase I Study of INVAC-1 as a Single Agent in Patients With Advanced Cancer
Lead sponsor
Invectys
Phase
Phase 1
Overall status
Completed
Start date
November 30, 2014
Completion date
June 1, 2018
Enrollment
26 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

solid tumors